Paraoxonase levels in women with polycystic ovary syndrome
OBJECTIVE: To determine paraoxonase (PON1) levels and whether paraoxonase activity is associated with an increased propensity for the development of cardiovascular disease in women with polycystic (PCOS)
Fenkci, S +3 more
core
Comparison of serum paraoxonase 1, butyrylcholinesterase, and carboxylesterase activities among dogs, cats, micro-mini pigs, and goats. [PDF]
Doi S +8 more
europepmc +1 more source
Paraoxonase enzyme activity and dyslipidemia in chronic kidney disease patients [PDF]
Mehrdad Solati, Hamid-Reza Mahboobi
doaj +1 more source
Association of <i>PON1</i> Q192R/L55M Polymorphisms and Paraoxonase-1 levels with cardiometabolic risk in patients with type-2 diabetes mellitus. [PDF]
Ahmed AM +4 more
europepmc +1 more source
IMPACT OF CARBAZOLE P-LACTAM DERIVATIVES ON PARAOXONASE-1 ACTIVITY
Paraoxonase 1 (PON1) is an antioxidant enzyme associated with high-density lipoproteins (HDL). PON1 has the ability to inhibit lipid peroxides and to hydrolyze a wide variety of substrates such as esters, thioesters, phosphotriesterases, carbonates ...
Arlinda Bytyqi-Damoni +5 more
core
Serum paraoxonase-1 as a marker of oxidative stress and pulmonary dysfunction in sarcoidosis: association with disease activity and prognostic potential. [PDF]
Bozkürk MB +5 more
europepmc +1 more source
Impact Of Carbazole P-Lactam Derıvatıves On Paraoxonase-1 Actıvıty
Paraoxonase 1 (PON1) is an antioxidant enzyme associated with high-density lipoproteins (HDL). PON1 has the ability to inhibit lipid peroxides and to hydrolyze a wide variety of substrates such as esters, thioesters, phosphotriesterases, carbonates ...
Arlinda Bytyqi-Damoni +7 more
core
Reduced Serum PON1 Lactonase Activity Is Associated with Mild Cognitive Impairment and Mixed Dementia. [PDF]
Riccetti R +9 more
europepmc +1 more source
A Pilot Study Exploring Paraoxonase-1 Tissue Protein Expression and Circulating Levels in Bladder Cancer. [PDF]
Parada D +6 more
europepmc +1 more source
Paraoxonase 2 as a target for aging-related diseases. [PDF]
Kim HH +5 more
europepmc +1 more source

